Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension
Go back to Amneal Receives U.S. FDA Approval for Risperidone Extended-Release Injectable Suspension| AmerElite Solutions, Inc. New (NASDAQ: AMRX) | Delayed: 19.57 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.57 | 52 Week High | $0.19 | |||
| Open | $19.57 | 52 Week Low | $0.07 | |||
| Day High | $19.57 | P/E | N/A | |||
| Day Low | $19.57 | EPS | $-0.01 | |||
| Volume | 1 | |||||



